product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
p44 MAP Kinase (Erk1) Antibody
catalog :
4372S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation
citations: 3
Published Application/Species/DilutionReference
  • western blot; human
Zhang D, Zhu L, Li C, Mu J, Fu Y, Zhu Q, et al. Sialyltransferase7A, a Klf4-responsive gene, promotes cardiomyocyte apoptosis during myocardial infarction. Basic Res Cardiol. 2015;110:28 pubmed publisher
  • western blot; human; fig 4
Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Raghuram G, et al. Integrated genomics approach to identify biologically relevant alterations in fewer samples. BMC Genomics. 2015;16:936 pubmed publisher
  • western blot; rat
Wang Y, Xiao X, Li N, Yang D, Xing Y, Huo R, et al. Oestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy. Br J Pharmacol. 2015;172:5586-95 pubmed publisher
product information
SKU :
4372S
Product-Name :
p44 MAP Kinase (Erk1) Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
M, R
Applications :
Immunoprecipitation
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
44
Host :
Rabbit
Target :
ERK1
Primary-Protein :
ERK1
Alt-Names :
ERK-1,ERK1,ERT2,Extracellular signal-regulated kinase 1,HS44KDAP,HUMKER1A,Insulin-stimulated MAP2 kinase,MAP kinase 1,MAP kinase 3,MAP kinase isoform p44,MAPK 1,MAPK 3,MAPK3,MGC20180,MK03,Microtubule-associated protein 2 kinase,Mitogen-activated protein kinase 1,Mitogen-activated protein kinase 3,P44ERK1,P44MAPK,PRKM3,extracellular signal-related kinase 1,p44-ERK1,p44-MAPK
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.